MINNEAPOLIS, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) announced that at the Special Meeting of Shareholders held earlier today, Vascular Solutions shareholders...
Progenics Pharmaceuticals and Shutterfly to Join S&P SmallCap 600 PR Newswire NEW YORK, Feb. 15, 2017 NEW YORK, Feb. 15, 2017 /PRNewswire/ -- Effective with this press release, S&P Dow...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Vascular Solutions, Inc. - VASC PR Newswire NEW YORK, Jan. 18, 2017 NEW YORK, Jan. 18, 2017 /PRNewswire/ -- Juan...
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Vascular Solutions, Inc. (“Vascular Solutions”) (NASDAQ:VASC) stock prior...
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...
Vascular Solutions, Inc. Acquisition May Not Be in the Best Interests of VASC Shareholders PR Newswire NEW YORK, Dec. 13, 2016 NEW YORK, Dec. 13, 2016 /PRNewswire/ -- WeissLaw LLP is...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Vascular Solutions, Inc. to Teleflex Incorporated for $24 Per Share is Fair to Shareholders...
VASCULAR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Vascular Solutions, Inc. (VASC) Over the Proposed Sale of the Company to Teleflex Incorporated PR Newswire NEW...
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Vascular Solutions, Inc. (“Vascular Solutions”) (NASDAQ:VASC) stock prior...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales